Mr. Alan J. Aubrey is Non-Executive Chairman at Ceres Power Holdings plc, Chairman of United Kingdom Department for Business, Innovation & Skills, Non-Executive Chairman at Modern Biosciences Plc and Non-Executive Chairman at Proactis Holdings Plc.
He is on the Board of Directors at Oxford Sciences Innovation Plc, Avacta Group Plc, IP Group Plc, Aquarius Equity Partners Ltd., Avacta Ltd., Axiomlab Investments Ltd., Axiomlab Plc, Hatt III General Partner Ltd., Inhoco 2835 Ltd., IP Industry Partners Ltd., IP2IP0 Ltd., IP2IP0 Management II Ltd., IP2IP0 Management IV Ltd., IP2IP0 Management Ltd., IP2IPO Services Ltd., LifeUK (IP2IP0) Ltd., PROACTIS Group Ltd., Syntopix Ltd., Techtran Corporate Finance Ltd., Techtran Investments Ltd., Techtran Services Ltd., TTV IV GP Ltd., Axiomlab Group Ltd. and Oxford Nanopore Technologies Ltd.
Mr. Aubrey was previously employed as Non-Executive Director by Tissue Regenix Group Plc, Non-Executive Director by Kanyon Plc, Partner by KPMG LLP (United Kingdom), Non-Executive Director by Energetix Group Plc, Non-Executive Director by Evocutis Plc, Non-Executive Director by Photopharmica Ltd., Non-Executive Director by Sustainable Resource Solutions Ltd., and Chief Executive Officer by Techtran Group Ltd.
He also served on the board at Salunda Ltd. and Surrey NanoSystems Ltd.
He received his undergraduate degree from the University of Leeds and an MBA from the University of Bradford.